Type 2

Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings.

BACKGROUND: A see on cardiovascular diseases and bladder cancer. The changes to the patterns of rosiglitazone and pioglitazone utilisation in Australia following the timing of these various health authority warnings such as the Australian Therapeutic …